Genetic defects in patients with glycogenosis type II (acid maltase deficiency)
Nina Raben(APT Therapeutics (United States)), Paul H. Plötz(National Institutes of Health), Cornelius F. Boerkoel(Child and Family Research Institute), Ralph C. Nichols
Cited by 52
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395